Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study
Abstract Background Hepatitis C virus (HCV) infection is a high prevalent disease. Sofosbuvir/ledipasvir (SOF/LDV) can successfully treat HCV and it was until recently that SOF/LDV was approved by the FDA in haemodialysis patients, but not in patients with liver cirrhosis. This study reports patient...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SpringerOpen
2021-10-01
|
| Serie: | Egyptian Liver Journal |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s43066-021-00150-3 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|